2m 2m 2m 2m 2m 2m 2m
ENvue Medical (FEED)
NASDAQ
$0.39+$0.002 (+0.61%)
Price as of Aug 21, 2026 7:54 PM EDT- $3.6MMarket Cap
- -89.97%1-Year Change
- Medical DevicesIndustry
ENvue Medical (FEED)
$0.39+$0.002 (+0.61%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.6M -0.20% | 2.6M +12.05% | 2.3M +203.59% | 752,000 -55.63% | |
Cost of Revenue | N/A N/A | 1.1M +40.75% | 746,000 +27.52% | 585,000 -36.76% | |
Gross Profit | 153,000 -89.85% | 1.5M -1.89% | 1.5M +820.36% | 167,000 -78.31% | |
Sales and Marketing Expense | N/A N/A | 720,000 -16.67% | 864,000 -10.47% | 965,000 -12.35% | |
Research and Development Expense | N/A N/A | -909,000 +391.35% | -185,000 -34.63% | -283,000 -3.41% | |
Depreciation and Amortization Expense | 897,000 +89,600.00% | 1,000 0.00% | 1,000 0.00% | 1,000 -50.00% | |
Total Operating Expenses | 23.0M +352.69% | 5.1M +2.35% | 5.0M -3.98% | 5.2M -19.74% | |
Operating Profit | -22.9M +539.00% | -3.6M +4.25% | -3.4M -31.44% | -5.0M -11.81% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | -135,000 0.00% | -135,000 -61.10% | -347,000 N/A | |
Interest Income and Expense and Net | 0 +100.00% | -135,000 0.00% | -135,000 -61.10% | -347,000 N/A | |
Total Nonoperating Income and Expense | N/A N/A | 135,000 0.00% | 135,000 -61.10% | 347,000 N/A | |
Income before Taxes | -18.5M +401.68% | -3.7M +0.11% | -3.7M -31.98% | -5.4M -62.01% | |
Income Taxes | -307,000 -1,715.79% | 19,000 -34.48% | 29,000 -17.14% | 35,000 +9.38% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -16.8M +352.77% | -3.7M -0.16% | -3.7M -31.88% | -5.4M -61.85% | |
Net Income from Continuing Operations Applicable to Common | -16.8M +352.77% | -3.7M -0.16% | -3.7M -31.88% | -5.4M -61.87% | |
Basic EPS and Net Income | -26.69 +94.39% | -13.73 +547.64% | -2.12 -44.79% | -3.84 +573.68% | |
Diluted EPS and Net Income | -26.69 +94.39% | -13.73 +547.64% | -2.12 -44.79% | -3.84 +573.68% | |
Basic Weighted Average Shares | 628,534 +132.92% | 269,848 -84.58% | 1.8M +23.28% | 1.4M -94.36% | |
Diluted Weighted Average Shares | 628,534 +132.92% | 269,848 -84.58% | 1.8M +23.28% | 1.4M -94.36% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.2M +461.70% | 752,000 -77.09% | 3.3M +21.01% | 2.7M -64.93% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 4.2M +461.70% | 752,000 -77.09% | 3.3M +21.01% | 2.7M -64.93% | |
Total Current Assets | 7.3M +118.28% | 3.3M -48.65% | 6.5M +15.65% | 5.6M -32.76% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 119,000 +1,222.22% | 9,000 +28.57% | 7,000 0.00% | 7,000 +40.00% | |
Total Long-Term Assets | 33.9M +11,260.07% | 298,000 +59.36% | 187,000 -30.74% | 270,000 -3.57% | |
Total Assets | 41.1M +1,033.20% | 3.6M -45.62% | 6.7M +13.52% | 5.9M -31.81% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 1.1M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 6.7M +144.67% | 2.7M +10.92% | 2.5M +5.96% | 2.3M +21.70% | |
Total Long-Term Debt | 1.1M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 28,000 -56.25% | 64,000 +326.67% | 15,000 -85.98% | 107,000 -30.07% | |
Total Liabilities | 7.6M +154.06% | 3.0M +11.76% | 2.7M +1.51% | 2.6M +14.60% | |
Retained Earnings | -90.5M +29.63% | -69.8M +5.61% | -66.1M +5.95% | -62.4M +9.57% | |
Total Stockholders Equity | N/A N/A | N/A N/A | 4.0M +23.35% | 3.2M -48.79% | |
Total Shares Outstanding | 1.1M +190.39% | 378,941 -81.48% | 2.0M +24.69% | 1.6M -94.14% | |
Cash Flow | |||||
Cash from Operating Activities | -9.4M +272.50% | -2.5M -30.15% | -3.6M -48.80% | -7.0M +61.09% | |
Capital Expenditures | 60,000 +1,900.00% | 3,000 +200.00% | 1,000 -66.67% | 3,000 0.00% | |
Cash from Investing Activities | 88,000 +3,033.33% | -3,000 +200.00% | -1,000 -66.67% | -3,000 0.00% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 12.8M +1,278,500.00% | 1,000 -99.98% | 4.2M +101.82% | 2.1M -54.32% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 58.95% -12.43% | 67.32% +203.16% | 22.21% -51.11% | |
Operating Margin | -896.55% +540.25% | -140.03% -6.96% | -150.50% -77.42% | -666.49% +98.79% | |
Return on Assets | -74.97% +4.24% | -71.92% +21.64% | -59.13% -21.31% | -75.14% -55.67% | |
Return on Equity | N/A N/A | N/A N/A | -102.78% -9.95% | -114.14% -65.21% | |
Revenue Growth | -0.20% -101.62% | 12.05% -94.08% | 203.59% +465.94% | -55.63% -132.33% | |
Current Ratio | 1.09 -10.79% | 1.22 -53.71% | 2.64 +9.15% | 2.42 -44.75% | |
Cash Ratio | 0.63 +129.53% | 0.28 -79.35% | 1.34 +14.21% | 1.17 -71.19% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.05 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow